Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Neurocrine Biosciences Looking Forward To A Big Year
Seeking Alpha
Thursday, November 6, 2014 - 2:57pm
tags:
Neurocrine Biosciences
Myriad Genetics Down on Earnings, Revenue Miss in Q1
Yahoo/Zacks.com
Thursday, November 6, 2014 - 2:54pm
tags:
Myriad Genetics, earnings
Sanofi, armed with more strong PhIII dengue data, sets sights on 2015 rollout
Fierce Vaccines
Thursday, November 6, 2014 - 11:44am
tags:
Sanofi, dengue, vaccines
Oops! Did FDA Mistakenly Give Ranbaxy Approval to Sell Generic Nexium?
WSJ Pharmalot
Thursday, November 6, 2014 - 10:57am
tags:
FDA, generics, AstraZeneca, Nexium, Ranbaxy
Pharmaceutical industry gets high on fat profits
BBC News
Thursday, November 6, 2014 - 10:55am
tags:
earnings, pharma industry
Bill Gates is backing MicroCHIPS, a startup developing remote control hormonal birth control chips
Smithsonian
Thursday, November 6, 2014 - 10:42am
tags:
Bill Gates, birth control, devices
After A Long Year, An Update on Geron's Myelofibrosis Drug Is Disclosed
TheStreet.com
Thursday, November 6, 2014 - 10:39am
tags:
Geron, myelofibrosis, imetelstat
Pozen posts 3Q profit
Yahoo/AP
Thursday, November 6, 2014 - 10:35am
tags:
Pozen, earnings
The FDA's Oncologic Drugs Advisory Committee Will Likely Vote Against Novartis' Panobinostat
Seeking Alpha
Thursday, November 6, 2014 - 9:47am
tags:
FDA, advisory panels, Novartis, panobinostat, Multiple Myeloma
Actavis Said to Be in Active Takeover Discussions With Allergan
Bloomberg
Thursday, November 6, 2014 - 9:43am
tags:
Actavis, Allergan, M&A
Lilly gains new stomach cancer approval for Cyramza
Pharmaphorum
Thursday, November 6, 2014 - 9:41am
tags:
Eli Lilly, stomach cancer, Cyramza, FDA
Sovaldi's not the only superhero launch: Meet the rest of the pharma Avengers
Fierce Pharma Marketing
Thursday, November 6, 2014 - 9:03am
tags:
Sovaldi, Gilead Sciences, Eyelea, Tecfidera, Zytiga, Kalydeco, Vertex Pharmaceuticals, Victoza, Novo Nordisk, Gilenya, Yervoy, Xtandi, Stribild, Stelara
A tale of two studies: Prescribe Pradaxa 'with caution'? Or rely on FDA's safety backing?
Fierce Pharma Marketing
Thursday, November 6, 2014 - 8:58am
tags:
Pradaxa, Boehringer Ingelheim, FDA
Memo to Sanofi: AstraZeneca’s Soriot Says He’s Australian
Bloomberg
Thursday, November 6, 2014 - 8:20am
tags:
Sanofi, Pascal Soriot, Pharma CEOs
Aegerion Buys Rare Disease Therapy, Seeking Path Out of Current Troubles
TheStreet.com
Thursday, November 6, 2014 - 8:19am
tags:
Aegerion, Myalept, AstraZeneca, lipodystrophy
Keryx Biopharma misses Street 3Q forecasts
Yahoo/AP
Thursday, November 6, 2014 - 8:06am
tags:
earnings, Keryx
Sucampo posts profit of $1.5 million in third quarter
Yahoo/AP
Thursday, November 6, 2014 - 8:05am
tags:
Sucampo, earnings
Perrigo to buy Belgium's Omega Pharma for $3.11 bln
Yahoo/Reuters
Thursday, November 6, 2014 - 8:01am
tags:
Perrigo, Omega Pharma, M&A
Ranbaxy loses six months exclusivity on Roche's antiviral drug
Yahoo/Reuters
Thursday, November 6, 2014 - 8:00am
tags:
Ranbaxy, Roche, generics, Valcyte, Nexium, AstraZeneca
AstraZeneca Is Building Value Without Pfizer, CEO Says
Bloomberg
Thursday, November 6, 2014 - 7:59am
tags:
AstraZeneca, Pfizer, M&A, Pascal Soriot, Pharma CEOs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.